Tag: Chemotherapy
PIK3CA Could Guide Use of COX-2 Inhibitors in Treatment for Colon Cancer
Patients with stage III resected colon cancer with PIK3CA gain-of-function mutations treated with celecoxib had improved DFS, OS
Racial, Ethnic Differences Seen in Breast Cancer Treatment Declination
American Indian, Alaska Native, other; Asian or Pacific Islander; Black patients more likely to decline surgery
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
Significant benefits in terms of three-year biochemical progression-free survival seen for NCHT versus neoadjuvant hormonal therapy
Bilateral Wilms Tumors That Grow During Chemo Mostly Stromal-Predominant
Patients with stromal-predominant tumors had the youngest age at diagnosis compared with other histologic subtypes
AACR: Cadonilimab Plus Chemo Beneficial for Gastric Adenocarcinoma
Improved overall survival, progression-free survival seen, including among patients with low PD-L1 expression
Simple Risk Score Predicts Severe Cisplatin-Linked Acute Kidney Injury
Simple risk score, including nine covariates, predicted risk for CP-AKI in monotonic manner in derivation, validation cohorts
Neoadjuvant Chemo Adds Significant Treatment Benefit in Penile Cancer
In a recent study, median overall survival with neoadjuvant chemotherapy, lymphadenectomy was 37.0 months
Treatment Modification Aids Chemo Tolerability in Seniors With Advanced Cancer
Primary treatment modifications tied to lower risk for toxic effects and functional decline
Tislelizumab Plus Chemotherapy Beneficial for Resectable NSCLC
Significant benefit seen for neoadjuvant tislelizumab plus chemotherapy with adjuvant tislelizumab
Pegargiminase + Chemo Increases Survival Rate in Nonepithelioid Pleural Mesothelioma
Improved median overall survival and progression-free survival seen for pegargiminase-based chemotherapy
